Johnson and Johnson revenue $20.74 billionChristian Fernsby ▼ | January 22, 2020
Johnson and Johnson announced results for Q4 2019.
Johnson and Johnson Pharmaceutical business posted revenue of $10.54 billion
Topics: Johnson and Johnson
Pharmaceutical business posted revenue of $10.54 billion, a 3.5% increase year over year.
The company’s consumer unit, which makes beauty products such as Neutrogena, increased 0.9% to $3.5 billion.
J&J’s medical device unit reported revenue of $6.63 billion, down half a percent from last year.
Litigation expenses were $264 million in the quarter, compared to $1.29 billion a year ago.
The company sees 2020 earnings between $8.95 per share and $9.10 a share. ■